Notice of Refund | Nov 16, 2018 | PAPER | BOARD |
Petitioner's Request for Refund | Oct 26, 2018 | PAPER | PETITIONER |
Granting Joint Motion to Expunge
37 C.F.R. sec 42.5 | Sep 28, 2018 | PAPER | BOARD |
Joint Motion to Expunge Exhibit 2025 Under 37 C.F.R. Section 42.56 | Sep 26, 2018 | PAPER | PATENT OWNER |
Decision Granting Joint Motion to Terminate
Due to Settlement Prior to Institution | Sep 10, 2018 | PAPER | BOARD |
Joint Motion to Terminate Proceedings | Sep 5, 2018 | PAPER | PATENT OWNER |
EXPUNGED | Sep 5, 2018 | EXHIBIT | PATENT OWNER |
Joint Request to Treat Binding Term Sheet (EX2025) as Business Confidential Information | Sep 5, 2018 | PAPER | PATENT OWNER |
Patent Owner's Updated Exhibit List as of September 5, 2018 | Sep 5, 2018 | PAPER | PATENT OWNER |
Minivelle¿¿ Product Label | Aug 22, 2018 | EXHIBIT | PATENT OWNER |
J. Hadgraft and R. Guy, Feasibility Assessment in Topical and Transdermal Delivery, in TRANSDERMAL DRUG DELIVERY 3-4 (R. Guy & J. Hadgraft eds., 2d ed. 2003) | Aug 22, 2018 | EXHIBIT | PATENT OWNER |
Patent Owner Preliminary Response | Aug 22, 2018 | PAPER | PATENT OWNER |
Declaration of Dr. Adrian C. Williams | Aug 22, 2018 | EXHIBIT | PATENT OWNER |
Curriculum Vitae of Dr. Adrian C. Williams | Aug 22, 2018 | EXHIBIT | PATENT OWNER |
B. Barry, Transdermal Drug Delivery, in AULTON'S PHARMACEUTICS ¿¿¿ THE DESIGN AND MANUFACTURE OF MEDICINES 565, 571-72, 577 (M. Aulton ed., 3d ed. 2007) | Aug 22, 2018 | EXHIBIT | PATENT OWNER |
A. Williams & B. Barry, Chemical Permeation Enhancement, in ENHANCEMENT IN DRUG DELIVERY 233, 248-50 (E. Touitou & B. Barry eds., 2007) | Aug 22, 2018 | EXHIBIT | PATENT OWNER |
A. Williams & B. Barry, The enhancement index concept applied to terpene penetration enhancers for human skin and model lipophilic (oestradiol) and hydrophilic (5-fluorouracil) drugs, 74 INT'L J. PHARMACEUTICS 157-168 (1991) | Aug 22, 2018 | EXHIBIT | PATENT OWNER |
Google Scholar search results obtained March 7, 2018 ¿¿¿ citations of Kim et al., Penetration Enhancement of ¿¿2-Selective Agonist, Tulobuterol, Across Hairless Mouse Skin, J. Pharm. Invest. 33: 79-84 (2003) | Aug 22, 2018 | EXHIBIT | PATENT OWNER |
U.S. Patent No. 8,029,820 | Aug 22, 2018 | EXHIBIT | PATENT OWNER |
R. Hinz et al., In vitro percutaneous penetration: evaluation of the utility of hairless mouse skin, 93(1) J. INVEST. DERMATOL. 87-91 (1989) | Aug 22, 2018 | EXHIBIT | PATENT OWNER |
R. Subedi et al., Influence of formulation variable in transdermal drug delivery system containing zolmitriptan, 419 INT'L J. PHARMACEUTICS 209-214 (2011) | Aug 22, 2018 | EXHIBIT | PATENT OWNER |
Comparison of Claims 1-15 of U.S. 9,833,419 and U.S. 9,724,310 | Aug 22, 2018 | EXHIBIT | PATENT OWNER |
J. Hadgraft, Passive enhancement strategies in topical and transdermal drug delivery, 184 INT'L J. PHARMACEUTICS 1-6 (1999) | Aug 22, 2018 | EXHIBIT | PATENT OWNER |
A. Williams & B. Barry, Urea analogues in propylene glycol as penetration enhancers in human skin, 36 INT'L J. PHARMACEUTICS 43-50 (1989) | Aug 22, 2018 | EXHIBIT | PATENT OWNER |
K. Brain & R. Chilcott, Physicochemical Factors Affecting Skin Absorption, in PRINCIPLES AND PRACTICE OF SKIN TOXICOLOGY 83-92 (R. Chilcott and S. Price eds., 2008) | Aug 22, 2018 | EXHIBIT | PATENT OWNER |
Esclim Product Label | Aug 22, 2018 | EXHIBIT | PATENT OWNER |
K. Walters & K. Brain, Dermatological Formulation and Transdermal Systems, in DERMATOLOGICAL AND TRANSDERMAL FORMULATIONS 338-43 (K. Walters, ed., 2002) | Aug 22, 2018 | EXHIBIT | PATENT OWNER |
A. Ghosh et al., Current Pharmaceutical Design on Adhesive Based Transdermal Drug Delivery Systems, 21 CURR. PHARM. DESIGN 2771-2783 (2015) | Aug 22, 2018 | EXHIBIT | PATENT OWNER |
B. Godin & E. Touitou, Transdermal skin delivery: Predictions for humans from in vivo, ex vivo and animal models, 59(11) ADV. DRUG DELIV. REVIEWS 1152-1161 (2007) | Aug 22, 2018 | EXHIBIT | PATENT OWNER |
J. Bond & B. Barry, Hairless mouse skin is limited as a model for assessing the effects of penetration enhancers in human skin, 90(6) J. INVEST. DERMATOL. 810-813 (1988) | Aug 22, 2018 | EXHIBIT | PATENT OWNER |
R. Subedi et al., Formulation and in vitro evaluation of transdermal drug delivery system for donezil, 42 J. PHARMA. INVEST. 1-7 (2012) | Aug 22, 2018 | EXHIBIT | PATENT OWNER |
J. van de Sandt et al., In vitro predictions of skin absorption of caffeine, testosterone, and benzoic acid: a multi-centre comparison study, 39 REG. TOXICOL. PHARMACOL. 271¿¿¿281 (2004) | Aug 22, 2018 | EXHIBIT | PATENT OWNER |
Noven Pharmaceuticals, Inc.'s First Updated Mandatory Notice Under 37 C.F.R. Section 42.8 | Jun 28, 2018 | PAPER | PATENT OWNER |
Patent Owner Mandatory Notices | Jun 7, 2018 | PAPER | PATENT OWNER |
Notice of Accord Filing Date | May 23, 2018 | PAPER | BOARD |
Petitioner's Power of Attorney | May 18, 2018 | PAPER | PETITIONER |
EX1001 U.S. Patent No. 9,833,419 to Mantelle | May 18, 2018 | EXHIBIT | PETITIONER |
EX1002 Brain Declaration | May 18, 2018 | EXHIBIT | PETITIONER |
EX1003 Brain CV | May 18, 2018 | EXHIBIT | PETITIONER |
EX1007 US Pat Pub 20060078602 to Kanios | May 18, 2018 | EXHIBIT | PETITIONER |
EX1008 Vivelle Label FOI Affidavit and Doc 5210567A | May 18, 2018 | EXHIBIT | PETITIONER |
EX1009 US Patent No. 5,145,682 to Chien | May 18, 2018 | EXHIBIT | PETITIONER |
EX1010 Kim | May 18, 2018 | EXHIBIT | PETITIONER |
EX1013 US Patent No. 5,919,477 to Bevan | May 18, 2018 | EXHIBIT | PETITIONER |
EX1014 Ghosh | May 18, 2018 | EXHIBIT | PETITIONER |
EX1015 Climara - Document #5243107A | May 18, 2018 | EXHIBIT | PETITIONER |
EX1016 Alora - Document #5210490A | May 18, 2018 | EXHIBIT | PETITIONER |
EX1017 Menostar - Document #5228320A | May 18, 2018 | EXHIBIT | PETITIONER |
EX1020 US Patent No. 6,521,250 to Meconi | May 18, 2018 | EXHIBIT | PETITIONER |
EX1004 U.S. 9,833,419 File History | May 18, 2018 | EXHIBIT | PETITIONER |
EX1005 US Pat Pub 20030099695 to Mueller | May 18, 2018 | EXHIBIT | PETITIONER |
EX1006 Vivelle-Dot Label FOI Affidavit and Doc 5236149B | May 18, 2018 | EXHIBIT | PETITIONER |
EX1011 US Patnt No. 5,656,286 to Miranda | May 18, 2018 | EXHIBIT | PETITIONER |
EX1012 WO 1996003119 to Fotinos | May 18, 2018 | EXHIBIT | PETITIONER |
EX1018 US Patent No. 5,902,602 to Muller | May 18, 2018 | EXHIBIT | PETITIONER |
EX1019 US Patent No. 6,156,335 to Rovati | May 18, 2018 | EXHIBIT | PETITIONER |
EX1021 US Patent No. 5,227,169 to Heiber | May 18, 2018 | EXHIBIT | PETITIONER |
EX1023 Dinger - Noven Pharmaceuticals, Inc | May 18, 2018 | EXHIBIT | PETITIONER |
EX1025 van der Bijl | May 18, 2018 | EXHIBIT | PETITIONER |
EX1030 US Patent No. 6,638,528 to Kanios | May 18, 2018 | EXHIBIT | PETITIONER |
EX1034 The Orange Book | May 18, 2018 | EXHIBIT | PETITIONER |
EX1022 Bucks | May 18, 2018 | EXHIBIT | PETITIONER |
EX1024 Butschhli - Tiny Patch 'Dots' Pharmaceutical Landscape | May 18, 2018 | EXHIBIT | PETITIONER |
EX1026 Bronaugh | May 18, 2018 | EXHIBIT | PETITIONER |
EX1031 US Patent No. 4,624,665 to Nuwayser | May 18, 2018 | EXHIBIT | PETITIONER |
EX1033 US Patent No. 6,024,976 to Miranda | May 18, 2018 | EXHIBIT | PETITIONER |
EX1035 US 9,730,900 File History Part 1 of 2 | May 18, 2018 | EXHIBIT | PETITIONER |
EX1035 US 9,730,900 File History Part 2 of 2 | May 18, 2018 | EXHIBIT | PETITIONER |
EX1037 US 9,724,310 to Mantelle | May 18, 2018 | EXHIBIT | PETITIONER |
EX1038 US 9,724,310 File History Part 1 of 2 | May 18, 2018 | EXHIBIT | PETITIONER |
EX1038 US 9,724,310 File History Part 2 of 2 | May 18, 2018 | EXHIBIT | PETITIONER |
EX1040 Mantelle | May 18, 2018 | EXHIBIT | PETITIONER |
EX1042 DE10012908 | May 18, 2018 | EXHIBIT | PETITIONER |
EX1028 US Patent No. 5,603,947 to Wong | May 18, 2018 | EXHIBIT | PETITIONER |
EX1039 Benson | May 18, 2018 | EXHIBIT | PETITIONER |
EX1041 Mantelle | May 18, 2018 | EXHIBIT | PETITIONER |
EX1027 US Patent No. 5,352,457 to Jenkins | May 18, 2018 | EXHIBIT | PETITIONER |
Petition for Inter Partes Review of US 9,833,419 | May 18, 2018 | PAPER | PETITIONER |